首页> 美国卫生研究院文献>Cell Death Disease >MicroRNA miR-4779 suppresses tumor growth by inducing apoptosis and cell cycle arrest through direct targeting of PAK2 and CCND3
【2h】

MicroRNA miR-4779 suppresses tumor growth by inducing apoptosis and cell cycle arrest through direct targeting of PAK2 and CCND3

机译:MicroRNA miR-4779通过直接靶向PAK2和CCND3诱导凋亡和细胞周期阻滞来抑制肿瘤生长

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Depending on the function of their target genes, microRNAs (miRNAs) act as either tumor suppressors or oncogenes. Therefore, miRNAs represent a novel therapeutic strategy for prevention and management of cancer by targeting of onco-miRNAs or mimicking of tumor suppressor miRNAs. Herein, we identified novel tumor suppressor miRNAs and investigated their molecular mechanisms. To identify novel tumor suppressor miRNAs, we used 532 human miRNA mimic libraries and measured cell viability using MTS assays. The function of miR-4779 was then analyzed using cell cycle analyses and apoptosis, colony forming, and soft agar assays. Target genes of miR-4779 were predicted using TargetScan and miRDB databases and were confirmed using luciferase assays. Levels of miR-4779 and target genes in colon cancer tissue samples from patients were evaluated using qRT-PCR and western blotting analyses. Finally, in vivo tumor suppressive effects of miR-4779 were evaluated in HCT116 xenografts. In this study, miR-4779 inhibited cancer cell growth by inducing apoptosis and cell cycle arrest, and the putative survival factors PAK2 and CCND3 were identified as direct targets of miR-4779. In subsequent experiments, PAK2 knockdown induced cell cycle arrest and CCND3 knockdown induced cell cycle arrest and apoptosis. In addition, miR-4779 suppressed tumor growth and tumorigenesis in an in vivo HCT116 xenograft model. Finally, miR-4779 expression was low in 9 of 10 colon cancer tissues, whereas PAK2 and CCND3 expressions were significantly high in colon cancer tissues. The novel tumor suppressor miR-4779 inhibits cancer cell growth via cell cycle arrest and apoptosis by directly targeting PAK2 and CCND3. The present data indicate the potential of miR-4779 as a therapeutic target for miRNA-based cancer therapy.
机译:根据其靶基因的功能,微小RNA(miRNA)可以充当肿瘤抑制因子或致癌基因。因此,miRNA代表了通过靶向癌性miRNA或模仿肿瘤抑制miRNA来预防和控制癌症的新型治疗策略。在这里,我们确定了新型的肿瘤抑制miRNA,并研究了它们的分子机制。为了鉴定新型的肿瘤抑制miRNA,我们使用了532种人类miRNA模拟文库,并使用MTS测定法测量了细胞活力。然后使用细胞周期分析,凋亡,集落形成和软琼脂分析来分析miR-4779的功能。使用TargetScan和miRDB数据库预测miR-4779的靶基因,并使用萤光素酶测定法对其进行确认。使用qRT-PCR和Western印迹分析评估了患者结肠癌组织样品中miR-4779和靶基因的水平。最后,在HCT116异种移植物中评估了miR-4779的体内肿瘤抑制作用。在这项研究中,miR-4779通过诱导凋亡和细胞周期停滞来抑制癌细胞的生长,并且假定的生存因子PAK2和CCND3被确定为miR-4779的直接靶标。在随后的实验中,PAK2敲低诱导细胞周期停滞,而CCND3敲低诱导细胞周期停滞和凋亡。另外,miR-4779在体内HCT116异种移植模型中抑制了肿瘤生长和肿瘤发生。最后,在10个结肠癌组织中有9个组织的miR-4779表达低,而在结肠癌组织中PAK2和CCND3表达显着高。新型肿瘤抑制因子miR-4779通过直接靶向PAK2和CCND3,通过细胞周期停滞和凋亡抑制癌细胞的生长。本数据表明miR-4779作为基于miRNA的癌症治疗的治疗靶标的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号